Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2436041
Max Phase: Preclinical
Molecular Formula: C43H35ClN4O5S
Molecular Weight: 755.30
Molecule Type: Small molecule
Associated Items:
ID: ALA2436041
Max Phase: Preclinical
Molecular Formula: C43H35ClN4O5S
Molecular Weight: 755.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCc1c[nH]c2ccccc12)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)c1nc(C(=O)Nc2ccc(Cl)c(C(=O)O)c2)c(-c2ccccc2)s1
Standard InChI: InChI=1S/C43H35ClN4O5S/c44-35-21-18-31(24-34(35)43(51)52)46-41(50)39-40(29-11-5-2-6-12-29)54-42(48-39)37(47-38(49)22-17-30-25-45-36-14-8-7-13-33(30)36)23-27-15-19-32(20-16-27)53-26-28-9-3-1-4-10-28/h1-16,18-21,24-25,37,45H,17,22-23,26H2,(H,46,50)(H,47,49)(H,51,52)/t37-/m0/s1
Standard InChI Key: FBNXJOLCDQNHSC-QNGWXLTQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 755.30 | Molecular Weight (Monoisotopic): 754.2017 | AlogP: 9.51 | #Rotatable Bonds: 14 |
Polar Surface Area: 133.41 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.90 | CX Basic pKa: | CX LogP: 9.20 | CX LogD: 5.72 |
Aromatic Rings: 7 | Heavy Atoms: 54 | QED Weighted: 0.09 | Np Likeness Score: -0.94 |
1. Chen YT, Tang CL, Ma WP, Gao LX, Wei Y, Zhang W, Li JY, Li J, Nan FJ.. (2013) Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy., 69 [PMID:24090912] [10.1016/j.ejmech.2013.09.017] |
Source(1):